Perfil
Kjell Rensfeldt worked as a Principal at Biogen, Inc. and Q-Med AB.
He also worked at Moberg Pharma AB from 2007 to 2018, where he held the position of Chief Medical Officer & VP-Clinical Development from 2012 to 2013.
Antiguos cargos conocidos de Kjell Rensfeldt.
| Empresas | Cargo | Fin |
|---|---|---|
| MOBERG PHARMA AB | Director Técnico/Científico/I+D | 13/08/2018 |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| BIOGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Kjell Rensfeldt
